{"id":"NCT02257957","sponsor":"Universidad Nacional de Colombia","briefTitle":"Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye","officialTitle":"Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11-30","primaryCompletion":"2015-09-30","completion":"2016-04-20","firstPosted":"2014-10-07","resultsPosted":"2021-08-24","lastUpdate":"2021-08-24"},"enrollment":30,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Dry Eye","Sjogren Syndrome"],"interventions":[{"type":"DRUG","name":"PRP injection","otherNames":[]},{"type":"DRUG","name":"Standard care Hyaluronic acid eye drops","otherNames":[]}],"arms":[{"label":"Platelet -Rich Plasma (PRP)","type":"EXPERIMENTAL"},{"label":"Standard Care","type":"ACTIVE_COMPARATOR"}],"summary":"Dry eye is a chronic condition that decreases function and affect visual function with severe discapacity until now treatments are based in artificial eye drops. Platelet rich plasma has emerged as a strategy for cellular restoration, the purpose of this study is to evaluate their effects in lacrimal production and safety of this intervention in patients with severe dry eye.","primaryOutcome":{"measure":"Change From Baseline in Ocular Surface Staining","timeFrame":"90 days","effectByArm":[{"arm":"Platelet -Rich Plasma (PRP)","deltaMin":1.2,"sd":0.18},{"arm":"Standard Care","deltaMin":2.4,"sd":0.18}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["29970389"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":[]}}